학술논문
Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
Document Type
Article
Author
Godman, B.; Kurdi, A.; Bonanno, P.V.; Tubic, B.; Allocati, E.; Banzi, R.; Wladysiuk, M.; McTaggart, S.; Haque, M.; MacBride-Stewart, S.; Kalemeera, F.; Massele, A.; Hoxha, I.; Pekovic, V.M.; Petrova, G.; Tachkov, K.; Laius, O.; Harsanyi, A.; Inotai, A.; Jakupi, A.; Henkuzens, S.; Garuolienė, K.; Gulbinovič, J.; Rutkowski, J.; Mardare, I.; Fürst, J.; Pontes, C.; Zara, C.; Pedrola, M.T.; Akter, F.; Kwon, H.-Y.; Martin, A.P.; Wale, J.
Source
In: Journal of Applied Pharmaceutical Science . (Journal of Applied Pharmaceutical Science, 2022, 12(3):55-72)
Subject
Language
English
ISSN
22313354